Latest Articles

  • Posttraumatic stress disorder, depression, and suicide in veterans
    Leo Sher, MD, María Dolores Braquehais, MD, PhD and Miquel Casas, MD, PhD
    Cleveland Clinic Journal of Medicine February 2012, 79 (2) 92-97; DOI: https://doi.org/10.3949/ccjm.79a.11069

    In military veterans, depression, posttraumatic stress disorder, and suicidal thoughts are common and closely linked.

  • Talking to patients: Barriers to overcome
    Brian F. Mandell, MD, PhD
    Cleveland Clinic Journal of Medicine February 2012, 79 (2) 90; DOI: https://doi.org/10.3949/ccjm.79b.12002

    Not all patients think like doctors, but we need to be able to think like patients.

  • A 37-year-old man with a chronic cough
    Sandeep M. Patel, MD, Sheena S. Patel, BA and Robert Myers, MD
    Cleveland Clinic Journal of Medicine February 2012, 79 (2) 141-150; DOI: https://doi.org/10.3949/ccjm.79a.11010

    When asked, he revealed that he had been diagnosed with human immunodeficiency virus infection but had not been taking his medication.

  • Overcoming health care disparities via better cross-cultural communication and health literacy
    Anita D. Misra-Hebert, MD, FACP and J. Harry Isaacson, MD
    Cleveland Clinic Journal of Medicine February 2012, 79 (2) 127-133; DOI: https://doi.org/10.3949/ccjm.79a.11006

    Health care disparities have multiple causes. Poor communication is a cause that can be modified.

  • Chest pain followed by sudden collapse
    Hesham R. Omar, MD
    Cleveland Clinic Journal of Medicine February 2012, 79 (2) 110-112; DOI: https://doi.org/10.3949/ccjm.78a.10050

    A 51-year-old man, resuscitated from ventricular fibrillation, has ST elevation in leads V1 and V2. What is the likely cause?

  • New and future therapies for lupus nephritis
    Gerald B. Appel, MD
    Cleveland Clinic Journal of Medicine February 2012, 79 (2) 134-140; DOI: https://doi.org/10.3949/ccjm.78gr.11004

    Clinical trials show that less-toxic drugs, such as mycophenolate mofetil, are as effective as older, more-toxic ones.

  • Addressing disparities in health care
    Charles S. Modlin, MD, MBA
    Cleveland Clinic Journal of Medicine January 2012, 79 (1) 44-45; DOI: https://doi.org/10.3949/ccjm.79a.11167
  • Is niacin ineffective? Or did AIM-HIGH miss its target?
    Stephen J. Nicholls, MBBS, PhD
    Cleveland Clinic Journal of Medicine January 2012, 79 (1) 38-43; DOI: https://doi.org/10.3949/ccjm.79a.11166

    The AIM-HIGH trial (Atherothrombosis Intervention in Metabolic Syndrome With Low HDL/High Triglycerides: Impact on Global Health Outcomes) found, in an interim analysis, no cardiovascular benefit from taking extended-release niacin (Niaspan). In fact, there was a trend toward a greater risk of ischemic stroke, which did not reach statistical significance. But questions remain about this complex trial, which included intensive statin therapy in the active-treatment group and the control group.

  • Bugs, pundits, evolution, and the New Year
    Brian F. Mandell, MD, PhD
    Cleveland Clinic Journal of Medicine January 2012, 79 (1) 10; DOI: https://doi.org/10.3949/ccjm.79b.12001
  • Overcoming barriers to hypertension control in African Americans
    Taiye Odedosu, MD, Antoinette Schoenthaler, EdD, Dorice L. Vieira, MLS, MPH, MA, Charles Agyemang, PhD and Gbenga Ogedegbe, MD
    Cleveland Clinic Journal of Medicine January 2012, 79 (1) 46-56; DOI: https://doi.org/10.3949/ccjm.79a.11068

Pages